Gilead preps filing for hepatitis D therapy Hepcludex in USGilead Sciences is planning to file for approval of Hepcludex, its antiviral therapy for rare hepatitis D virus Share XGilead preps filing for hepatitis D therapy Hepcludex in UShttps://pharmaphorum.com/news/gilead-preps-filing-for-hepatitis-d-therapy-hepcludex-in-us/
